Patents by Inventor John D Rothermel

John D Rothermel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination comprising a signal transduction inhibitor and an epothilone derivative
    Patent number: 7723339
    Abstract: The present invention relates to a combination comprising N-{5-[4-(4-methyl-piperazino-methyl) -benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and an epothiione derivative; pharmaceutical composition comprising said combination; method of treatment comprising said combination; and commercial packages comprising said combination.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: May 25, 2010
    Assignee: Novartis AG
    Inventors: Ralf Brandt, Elisabeth Buchdunger, Carl-Henrik Heldin, Arne Östman, Kristian Pietras, Terence O'Reilly, John D Rothermel, Peter Traxler, Markus Wartmann
  • Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
    Publication number: 20040092478
    Abstract: Epothilone derivatives are co-administered with an antidiarrheal agent, e.g., a DPP-IV inhibitor, in the treatment of a proliferative disease.
    Type: Application
    Filed: September 15, 2003
    Publication date: May 13, 2004
    Inventors: John D. Rothermel, Horst F. Schran, Diane Greeley, TianLing Chen